Sramana Mitra: Funding was happening in Israel?
Rotem Shor: Seed and Series A was in Israel. In Round B, non-Israeli venture funds joined.
Sramana Mitra: By Series B, you had the third client?
Rotem Shor: Yes, but we had more of a thesis. We still got traction from users.
Sramana Mitra: How much money are we talking? Seed was $1 million.
>>>Sramana Mitra: How did the first one get the users?
Rotem Shor: They paid a very small amount of money. It was not only for a specific medication. They developed it as a tool. The second was very specific for their drug. We found out later that it is much harder than we thought.
Sramana Mitra: So what did you do?
>>>Sramana Mitra: You went to a pharma company before you had a product?
Rotem Shor: We developed a concept. Then we developed the MVP. We launched it to users. We launched the product and saw that users were coming. We did a lot of guerilla marketing. We combined it all together. We gained traction. We got strong feedback from patients on what to do and how to improve. Today, we are rated 4.7 in the app stores with more than 450,000 reviews by patients.
>>>Rotem represents yet another point of view of a software developer/technologist who successfully transitioned to an entrepreneur in an unfamiliar domain: pharmaceutical.
In that journey, he paired up with his brother who was more the business person in the duo. This is a common strategy for developers to become entrepreneurs, although, I generally
believe that developers can learn the business side as well.
The story also traces the pivots that were necessary to find product-market fit, as well as the failures that triggered each pivot.
>>>Sramana Mitra: Getting companies fundable is a high-touch process. That is not necessarily a scalable process. I would say we may be the only accelerator in the world that has done some scalability on that. We have created a lot of curriculum. We’ve done so many now. It’s like pattern matching. That takes time.
One of the things that we’ve done is we’ve released a large chunk of our curriculum on Udemy. Udemy has 50 million users. My point is, if you take on the job of trying to coach these people, that is very difficult. Then comes the issue of leading the round or just following.
>>>Sramana Mitra: What did you do after Art.com?
Josh Chodniewicz: We were in San Francisco. I moved to New York and lived a couple of years there. Frankly, I think I dealt with an identity crisis. All I knew was Art.com. I had to get around that. I started making investments in startups. I saw quite a bit of success in that.
Sramana Mitra: What did you invest in that really did well?
>>>Slava Bronfman: It was a better year in terms of sales. Earlier, a lot of our sales were based on physical conferences. It’s hard to compete as a small startup. If you go to a conference and you have a small booth, it’s hard to compete. Now remote working levels the playing field. We felt that it was easier for us to approach customers remotely. We have customers around the globe. We have customers in the United States, Europe, China, and Japan. It was relatively easier than before.
Sramana Mitra: I’ve heard this from a lot of startups. The pandemic has been a boon for them for exactly the same reasons.
>>>Sramana Mitra: We are now in 2004?
Josh Chodniewicz: 2001 was when we acquired Art.com. Then 2004 was when we raised $30 million and combined it with our leading competitor at that time called AllPosters. I called up the other CEO and said, “We can shoot bullets at each other or we can join and shoot them at the rest of the world.” We put the businesses together in 2005.
Sramana Mitra: You ran the company?
>>>